These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7059419)

  • 41. [Systematic review of studies assessing the cost of adverse drug reactions].
    Vallano Ferraz A; Agustí Escasany A; Pedrós Xolvi C; Arnau de Bolós JM
    Gac Sanit; 2012; 26(3):277-83. PubMed ID: 22152925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents.
    Cornelius VR; Liu K; Peacock J; Sauzet O
    BMJ Open; 2016 Mar; 6(3):e010599. PubMed ID: 26996819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
    Svendsen K; Wood M; Olsson E; Nordeng H
    Eur J Clin Pharmacol; 2018 May; 74(5):627-636. PubMed ID: 29290074
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linking biochemical pathways and networks to adverse drug reactions.
    Zheng H; Wang H; Xu H; Wu Y; Zhao Z; Azuaje F
    IEEE Trans Nanobioscience; 2014 Jun; 13(2):131-7. PubMed ID: 24893363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study on the Increased Probability of Detecting Adverse Drug Reactions Based on Bayes' Theorem: Evaluation of the Usefulness of Information on the Onset Timing of Adverse Drug Reactions.
    Oshima S; Enjuji T; Negishi A; Akimoto H; Ohara K; Okita M; Numajiri S; Inoue N; Ohshima S; Terao A; Kobayashi D
    Biol Pharm Bull; 2017 Sep; 40(9):1389-1398. PubMed ID: 28579595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study.
    Langerová P; Vrtal J; Urbánek K
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):560-4. PubMed ID: 24810357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survey of patients' experiences and their certainty of suspected adverse drug reactions.
    Narumol J; Arunrot P; Krska J
    Int J Clin Pharm; 2015 Feb; 37(1):168-74. PubMed ID: 25576461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse drug reactions in elderly patients following discharge from an internal medicine clinic.
    Marusic S; Sicaja M; Obreli Neto PR; Franic M; Marinovic I; Bacic-Vrca V
    Int J Clin Pharmacol Ther; 2014 Oct; 52(10):906-13. PubMed ID: 25066228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients.
    Kiguba R; Karamagi C; Bird SM
    BMJ Open; 2017 Jan; 7(1):e010568. PubMed ID: 28110281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study.
    Ahern F; Sahm LJ; Lynch D; McCarthy S
    Emerg Med J; 2014 Jan; 31(1):24-9. PubMed ID: 23389832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supervised signal detection for adverse drug reactions in medication dispensing data.
    Hoang T; Liu J; Roughead E; Pratt N; Li J
    Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The design of an algorithm for pharmacists to evaluate ADRs in the elderly.
    Trewin VF
    J Clin Pharm Ther; 1991 Feb; 16(1):45-53. PubMed ID: 2026668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.